| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Pradeep Kumar | Q37837571 |
| Viness Pillay | Q42181924 | ||
| Yahya E Choonara | Q61083095 | ||
| Lisa C du Toit | Q61816890 | ||
| P2093 | author name string | Pakama Mahlumba | |
| P2860 | cites work | Smart polymers for peptide and protein parenteral sustained delivery | Q86031666 |
| 19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 | Q95812970 | ||
| Potential and problems in ultrasound-responsive drug delivery systems | Q30454986 | ||
| Sonochemistry | Q30473646 | ||
| Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods | Q33371949 | ||
| The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study | Q33569881 | ||
| Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review | Q33726705 | ||
| Contrast echocardiography: current and future applications | Q33886229 | ||
| Mechanisms of action of cyclosporine. | Q33908049 | ||
| Ocular delivery of macromolecules | Q34079676 | ||
| Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group | Q34163974 | ||
| Phototriggering of liposomal drug delivery systems | Q34463650 | ||
| Hydrogels for biomedical applications | Q34469979 | ||
| A refillable microfabricated drug delivery device for treatment of ocular diseases | Q34789696 | ||
| Near-infrared light-responsive core-shell nanogels for targeted drug delivery. | Q35074514 | ||
| Glucose-responsive insulin delivery microhydrogels from methacrylated dextran/concanavalin A: preparation and in vitro release study | Q35153620 | ||
| Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors | Q42596925 | ||
| Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery | Q42697658 | ||
| Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution | Q42863673 | ||
| Light controlled protein release from a supramolecular hydrogel | Q43065321 | ||
| A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery | Q43147732 | ||
| pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles | Q43479806 | ||
| Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. | Q43715309 | ||
| In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride | Q43768872 | ||
| Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia | Q43903058 | ||
| Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo | Q44375435 | ||
| Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy | Q44489793 | ||
| Long-term doxorubicin release from multiple stimuli-responsive hydrogels based on α-amino-acid residues | Q44596111 | ||
| Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems | Q44672409 | ||
| Fabrication and characterization of a smart drug delivery system: microsphere in hydrogel | Q45189896 | ||
| In vitro, in vivo, and in silico evaluation of the bioresponsive behavior of an intelligent intraocular implant | Q45369102 | ||
| High-frequency ultrasound-responsive block copolymer micelle. | Q45942518 | ||
| Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries | Q46335254 | ||
| Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results | Q46387330 | ||
| Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules | Q46970820 | ||
| Polymer vesicles containing small vesicles within interior aqueous compartments and pH-responsive transmembrane channels. | Q47990617 | ||
| Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules. | Q48630771 | ||
| Sustained release intraocular drug delivery devices for treatment of uveitis | Q35835614 | ||
| In situ-forming hydrogels--review of temperature-sensitive systems | Q35857106 | ||
| Noninvasive routes of proteins and peptides drug delivery | Q36029817 | ||
| Treatment of conjunctival squamous neoplasias with interferon alpha 2ab. | Q37135347 | ||
| Recent advances in photoresponsive supramolecular self-assemblies. | Q37224390 | ||
| Treatment of chronic dry eye: focus on cyclosporine | Q37236096 | ||
| Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels. | Q37236355 | ||
| Recent perspectives in ocular drug delivery | Q37256549 | ||
| Smart polymer based delivery systems for peptides and proteins | Q37347761 | ||
| Stimuli-responsive polymers and their applications in drug delivery | Q37406643 | ||
| Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo | Q37513330 | ||
| Therapeutic application of peptides and proteins: parenteral forever? | Q37600236 | ||
| Delivery of therapeutic proteins | Q37668486 | ||
| Age-related macular degeneration: current and novel therapies | Q37706721 | ||
| Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives | Q37798126 | ||
| Consequences of oxidative stress in age-related macular degeneration | Q38003229 | ||
| The role of fibronectin in corneal wound healing explored by a physician-scientist | Q38031407 | ||
| Stimuli sensitive hydrogels for ophthalmic drug delivery: A review | Q38057242 | ||
| Current knowledge and trends in age-related macular degeneration: today's and future treatments. | Q38065879 | ||
| Nanomedicines for back of the eye drug delivery, gene delivery, and imaging | Q38100561 | ||
| In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. | Q38152173 | ||
| Nanotherapy for posterior eye diseases | Q38214989 | ||
| A critical assessment of in vitro tissue models for ADME and drug delivery | Q38226077 | ||
| Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems | Q38259425 | ||
| Recent Advances in Topical Ocular Drug Delivery | Q38669007 | ||
| Design of genipin-crosslinked microgels from concanavalin A and glucosyloxyethyl acrylated chitosan for glucose-responsive insulin delivery | Q39023846 | ||
| Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles | Q39479920 | ||
| Adaptable poly(ethylene glycol) microspheres capable of mixed-mode degradation | Q41900591 | ||
| Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. | Q42034917 | ||
| Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery | Q42573109 | ||
| An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. | Q53221125 | ||
| Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece. | Q53674348 | ||
| Pharmacokinetics of intravitreal ranibizumab (Lucentis). | Q55046220 | ||
| Delivery of drug macromolecules from thermally responsive gel implants to the posterior eye | Q57357269 | ||
| Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system | Q57360761 | ||
| Thermoresponsive Polymers for Biomedical Applications | Q57373252 | ||
| Enzyme-responsive hydrogel particles for the controlled release of proteins: designing peptide actuators to match payload | Q58422892 | ||
| o-Nitrobenzyl Alcohol Derivatives: Opportunities in Polymer and Materials Science | Q59442066 | ||
| Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group | Q67567097 | ||
| Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro | Q67976413 | ||
| Temperature controlled encapsulation and release using partially biodegradable thermo-magneto-sensitive self-rolling tubes | Q70853923 | ||
| Mechanistic Studies on Transcorneal Permeation of Fluorometholone | Q72417556 | ||
| In situ-forming gels for ophthalmic drug delivery | Q72527252 | ||
| Topical substance P and corneal epithelial wound closure in the rabbit | Q73089202 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin | Q79487019 | ||
| Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin | Q79664702 | ||
| Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex | Q81548659 | ||
| Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging | Q82142092 | ||
| Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin | Q83157817 | ||
| Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C | Q83959973 | ||
| Biodegradable and pH-sensitive polymersome with tuning permeable membrane for drug delivery carrier | Q84205969 | ||
| Issues in long-term protein delivery using biodegradable microparticles | Q84280594 | ||
| Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration | Q85124433 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| drug carrier | Q3715494 | ||
| P577 | publication date | 2016-07-30 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery | |
| P478 | volume | 21 |
| Q92752993 | Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery |
| Q37652843 | Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone |
| Q91714201 | Hydrogel Biomaterials for Application in Ocular Drug Delivery |
| Q39198309 | Intracellular delivery of proteins by nanocarriers |
| Q96130508 | Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations |
| Q98197151 | Nanotechnology-based antiviral therapeutics |
| Q47729137 | Ocular delivery of proteins and peptides: challenges and novel formulation approaches |
| Q92540208 | Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery |
| Q39351089 | Updates on smart polymeric carrier systems for protein delivery. |
Search more.